Maintenance management after dupilumab discontinuation in moderate-to-severe atopic dermatitis: a comparative study of proactive intermittent tacrolimus and reactive rescue therapy | Synapse
February 14, 2026Open Access
Maintenance management after dupilumab discontinuation in moderate-to-severe atopic dermatitis: a comparative study of proactive intermittent tacrolimus and reactive rescue therapy
Key Points
This research aims to compare proactive intermittent tacrolimus with reactive rescue therapy following dupilumab discontinuation in patients with moderate-to-severe atopic dermatitis.
Comparative study design
Assessment of proactive intermittent tacrolimus versus reactive rescue therapy
Evaluation of flare risk and steroid burden
Proactive tacrolimus significantly reduces flare risk compared to reactive therapy
Lower steroid usage observed in patients on proactive tacrolimus
Improved overall outcomes reported with proactive treatment strategy
Abstract
Proactive intermittent tacrolimus after dupilumab reduces flare risk and steroid burden, improving outcomes, and is a feasible maintenance strategy.